Effectiveness of Upadacitinib for Inflammatory Bowel Disease Patients With Pouchitis: Prospective Real-World Experience

被引：0
|
作者：
Cleveland, Noa Krugliak [1 ]
Choi, Natalie [1 ]
Choi, David K. [1 ]
Dalal, Sushila [1 ]
Rubin, David T. [1 ]
机构：
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1141
引用
收藏
页码：S873 / S874
页数：2
相关论文
共 50 条
  • [21] UPADACITINIB IS EFFECTIVE AND SAFE IN TOFACITINIB-EXPERIENCED PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-WORLD EXPERIENCE
    Cleveland, Noa
    Friedberg, Scott
    Choi, David
    Hunold, Thomas
    Choi, Natalie K.
    Garcia, Nicole M.
    Picker, Emma A.
    Cohen, Nathaniel A.
    Cohen, Russell D.
    Dalal, Sushila R.
    Pekow, Joel
    Sakuraba, Atsushi
    Rubin, David T.
    GASTROENTEROLOGY, 2023, 164 (06) : S1129 - S1129
  • [22] Safety of Upadacitinib in Older Patients With Ulcerative Colitis: A Real-World Experience
    Chowla, Navreet
    Tariq, Raseen
    Loftus, Edward
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S8 - S9
  • [23] Upadacitinib is Effective and Safe in Tofacitinib-Experienced Patients with Ulcerative Colitis: A Prospective Real-World Experience
    Cleveland, N. Krugliak
    Friedberg, S.
    Choi, D.
    Hunold, T.
    Choi, N. K.
    Garcia, N. M.
    Picker, E. A.
    Cohen, N. A.
    Cohen, R. D.
    Dalal, S. R.
    Pekow, J.
    Sakuraba, A.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 854 - 856
  • [24] Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease
    Smith, Philip J.
    Fumery, Mathurin
    Leong, Rupert W.
    Novak, Kerri
    Dignass, Axel
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (09) : 1143 - 1156
  • [25] REAL-WORLD EFFECTIVENESS AND SAFETY OF UPADACITINIB IN CROHN'S DISEASE: A MULTICENTER STUDY
    Devi, Jalpa
    Chowla, Navreet M.
    Khan, Abdul
    Huang, Katherine
    Reddy, Nikhil
    Pekow, Joel
    Patel, Anish
    Bishu, Shrinivas
    Shukla, Richa
    Fenster, Marc
    Ungaro, Ryan C.
    Yarur, Andres
    Johnson, Amanda M.
    Deepak, Parakkal
    GASTROENTEROLOGY, 2024, 166 (05) : S1452 - S1452
  • [26] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Stefan Schreiber
    Axel Dignass
    Laurent Peyrin-Biroulet
    Greg Hather
    Dirk Demuth
    Mahmoud Mosli
    Rebecca Curtis
    Javaria Mona Khalid
    Edward Vincent Loftus
    Journal of Gastroenterology, 2018, 53 : 1048 - 1064
  • [27] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Mosli, Mahmoud
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward Vincent, Jr.
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1048 - 1064
  • [28] Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study
    Thomas, Pepijn W. A.
    den Broeder, Nathan
    Derikx, Monique
    Kievit, Wietske
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    Romkens, Tessa E. H.
    Hoentjen, Frank
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (12) : 1813 - 1820
  • [29] Upadacitinib: A real-world tertiary Australian hospital experience
    Yogakanthi, S.
    Hartley, I.
    Ding, J. N.
    Schulberg, J.
    Connell, W.
    Kamm, M. A.
    Basnayake, C.
    Lust, M.
    Niewiadomski, O.
    Wright, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 152 - 152
  • [30] Real-world biologic treatment and associated cost in patients with inflammatory bowel disease
    Brandes, Alina
    Groth, Antje
    Gottschalk, Fraence
    Wilke, Thomas
    Ratsch, Boris A.
    Orzechowski, Hans-Dieter
    Fuchs, Andreas
    Deiters, Barthold
    Bokemeyer, Bernd
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (07): : 843 - 851
12345